Advertisement

Biotech startup HepatoChem Inc. has raised $100,000 in a initial funding round from New Jersey-based investor Heartland Bridge Capital Inc., under an agreement that could bring in $400,000 to HepatoChem.

SOURCE

Advertisement
Advertisement